Rankings
▼
Calendar
ALXO FY 2021 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena
ALXO
ALX Oncology Holdings Inc.
$112M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$84M
Net Income
-$83M
EPS (Diluted)
$-2.07
Cash Flow
Operating Cash Flow
-$68M
Free Cash Flow
-$73M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$380M
Total Liabilities
$17M
Stockholders' Equity
$363M
Cash & Equivalents
$364M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$1M
-100.0%
Gross Profit
$0
$107,000
-100.0%
Operating Income
-$84M
-$44M
-91.4%
Net Income
-$83M
-$46M
-82.5%
← Q4 2020
All Quarters
Q1 2021 →